Occlusive Treatment of Chronic Hand Dermatitis with Pimecrolimus Cream 1% Results in Low Systemic Exposure, Is Well Tolerated, Safe, and Effective

Publisher： Karger

E-ISSN： 1421-9832|207|1|37-42

ISSN： 1018-8665

Source： Dermatology, Vol.207, Iss.1, 2003-07, pp. : 37-42

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and Safety of Pimecrolimus Cream 1% in Mild-to-Moderate Chronic Hand Dermatitis: A Randomized, Double-Blind Trial

By  

Dermatology, Vol. 221, Iss. 1, 2010-06 ,pp. : 71-77

Karger

Access to resources Recommend Favorite

Discordant Results with Pimecrolimus 1% Cream in the Treatment of Plasma Cell Balanitis

By  

Dermatology, Vol. 218, Iss. 2, 2008-10 ,pp. : 155-158

Karger

Access to resources Recommend Favorite

Rosaceiform Dermatitis with Follicular Demodex after Treatment of Facial Atopic Dermatitis with 1% Pimecrolimus Cream

By  

Dermatology, Vol. 207, Iss. 2, 2003-08 ,pp. : 205-207

Karger

Access to resources Recommend Favorite

Low Systemic Exposure after Repeated Topical Application of Pimecrolimus (Elidel®, SD Z ASM 981) in Patients with Atopic Dermatitis

By  

Dermatology, Vol. 204, Iss. 1, 2002-04 ,pp. : 63-68

Karger

Access to resources Recommend Favorite

Steroid-Sparing Effect of Pimecrolimus Cream 1% in Children with Severe Atopic Dermatitis

By  

Dermatology, Vol. 215, Iss. 4, 2007-10 ,pp. : 325-330

Karger

Access to resources Recommend Favorite